Neurology · PANCE / PANRE

Brain Tumors (Primary and Metastatic)

Intracranial neoplasms — most common metastatic; among primary, gliomas (esp. glioblastoma) and meningiomas dominate adult disease.

Also known as: brain tumor, intracranial neoplasm, glioblastoma, GBM, meningioma, brain metastases, astrocytoma

Overview

Mass lesions of the brain parenchyma, meninges, cranial nerves, or skull base, classified as primary (arising from CNS tissue) or metastatic (spread from systemic cancer). Histology and molecular markers (per WHO 2021 CNS classification) drive prognosis and treatment.

Epidemiology

Brain metastases outnumber primary CNS tumors roughly 10:1. Among adult primary tumors, meningioma is most common overall; glioblastoma is the most common malignant primary (median survival ~15 months with maximal therapy). Lung, breast, melanoma, renal, and colorectal cancers account for the majority of brain metastases.

Try two board-style Brain Tumors questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1NeurologyMedium
A 58-year-old man is brought to the emergency department after a first-ever generalized seizure. For 3 weeks he has had worsening morning headaches, nausea, and progressive left-arm weakness. He has no fever and no history of cancer or recent infection. Examination shows left-sided pronator drift and early papilledema. MRI of the brain with gadolinium reveals a 4-cm irregularly enhancing right frontal mass with surrounding vasogenic edema and 6 mm of midline shift. Which of the following is the most appropriate initial management?
  • AStereotactic radiosurgery
  • BMannitol osmotic therapy
  • CHyperventilation therapy
  • DHigh-dose dexamethasone
  • ETemozolomide chemotherapy
Reveal answer & full explanation
Correct answer: D — High-dose dexamethasone
  • AStereotactic radiosurgery
  • BMannitol osmotic therapy
  • CHyperventilation therapy
  • DHigh-dose dexamethasone✓
  • ETemozolomide chemotherapy

Why High-dose dexamethasone is correct

  • The patient has a symptomatic brain mass with vasogenic edema and midline shift producing a focal deficit, headache, and papilledema; corticosteroids are first-line to reduce peritumoral edema and mass effect and rapidly relieve symptoms.
  • Per neuro-oncology practice, dexamethasone 4-10 mg load then 4 mg q6h is started for symptomatic edema while neurosurgery is consulted for tissue diagnosis and maximal safe resection.
  • A single irregularly enhancing frontal mass with no infectious history and no known primary fits a high-grade glioma (glioblastoma); this lesion is not periventricular/callosal and the patient is not immunosuppressed, so the lymphoma caveat (hold steroids until biopsy) does not apply.

Why the others are wrong

  • Temozolomide chemotherapy — part of the Stupp protocol for glioblastoma, but it is given only after surgical resection establishes WHO 2021 grade and molecular profile (IDH, MGMT); starting it now is premature.
  • Stereotactic radiosurgery — appropriate for small or oligometastatic deposits, not for a large primary mass with midline shift that needs steroids for edema and tissue diagnosis before any radiotherapy.
  • Hyperventilation therapy — lowering PaCO2 constricts cerebral vessels and drops intracranial pressure only transiently; it is a brief rescue maneuver for impending herniation, not initial management of an awake patient with no herniation signs, and it does nothing for the tumor vasogenic edema that corticosteroids relieve while risking ischemia from reduced cerebral blood flow.
  • Mannitol osmotic therapy — an osmotic agent that rapidly but transiently lowers intracranial pressure; like hyperventilation, it is a temporizing measure for clinical herniation, whereas corticosteroids durably reduce the peritumoral vasogenic edema causing this awake patient's symptoms.
Question 2NeurologyMedium
A 58-year-old man with a recently diagnosed right frontal glioblastoma is brought to the emergency department for worsening headache, vomiting, and progressive drowsiness over 12 hours. He had stopped his dexamethasone two days ago. Temperature is 37.0 C, blood pressure 178/96 mm Hg, pulse 52/min, and respirations are irregular. The right pupil is 6 mm and minimally reactive; the left is 3 mm and reactive. CT of the head shows the known right frontal mass with extensive surrounding vasogenic edema, midline shift, and effacement of the basal cisterns. Which of the following complications is he most likely developing?
  • AUncal transtentorial herniation
  • BSteroid-withdrawal adrenal crisis
  • CHemorrhage into the known tumor bed
  • DNonconvulsive status epilepticus
  • EAcute communicating hydrocephalus
Reveal answer & full explanation
Correct answer: A — Uncal transtentorial herniation
  • AUncal transtentorial herniation✓
  • BSteroid-withdrawal adrenal crisis
  • CHemorrhage into the known tumor bed
  • DNonconvulsive status epilepticus
  • EAcute communicating hydrocephalus

Why Uncal transtentorial herniation is correct

  • A large hemispheric tumor with extensive vasogenic edema and midline shift raises supratentorial pressure, forcing the medial temporal lobe (uncus) over the tentorial edge.
  • The compressed ipsilateral CN III produces a fixed, dilated pupil (here, the right 6 mm minimally reactive pupil), and brainstem compression causes the Cushing reflex (hypertension, bradycardia, irregular respirations) seen in this patient.
  • Effacement of the basal cisterns on CT and the abrupt decline after stopping dexamethasone (loss of edema control) point to impending herniation, a neurosurgical emergency requiring hyperosmolar therapy, steroids, and decompression.

Why the others are wrong

  • Hemorrhage into the known tumor bed - glioblastomas do bleed, but the CT here describes only the known mass with vasogenic edema and shift and reports no new hyperdensity; even when present, intratumoral hemorrhage is the precipitant of rising pressure rather than the syndrome defined by an ipsilateral blown pupil and the Cushing reflex.
  • Nonconvulsive status epilepticus - a frontal tumor is a real substrate for it and it can cause progressive obtundation, but it does not produce a unilaterally fixed dilated pupil, bradycardia with hypertension, or effacement of the basal cisterns.
  • Acute communicating hydrocephalus - results from impaired CSF absorption after subarachnoid hemorrhage or meningitis; supratentorial tumors more typically cause obstructive (noncommunicating) hydrocephalus, and the cisterns here are effaced rather than showing enlarged ventricles driving the picture.
  • Steroid-withdrawal adrenal crisis - stopping dexamethasone tempts this choice, and vomiting with drowsiness can occur in adrenal insufficiency, but adrenal crisis causes hypotension and shock rather than hypertension with bradycardia, and it cannot explain a unilateral dilated pupil or effaced basal cisterns; the steroid lapse matters here because it let the vasogenic edema rebound.

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Brain Tumors (Primary and Metastatic) outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Prior ionizing radiation to the head (strongest established environmental risk)
  • Hereditary syndromes: neurofibromatosis 1 and 2, tuberous sclerosis, Li-Fraumeni, Lynch, Turcot, von Hippel-Lindau
  • Immunosuppression (primary CNS lymphoma, especially in HIV)
  • Female sex and hormonal exposure (meningioma express progesterone receptors)
  • Known systemic malignancy with brain-tropic biology (lung, breast, melanoma)

Pathophysiology

Primary tumors arise from glial cells (astrocytes, oligodendrocytes, ependyma), arachnoid cap cells (meningioma), neurons, or embryonal precursors. Glioblastoma is characterized by IDH-wildtype status, TERT promoter mutations, EGFR amplification, and chromosome 7 gain / 10 loss; its histologic hallmarks are pseudopalisading necrosis and microvascular proliferation, and MRI shows a heterogeneous ring-enhancing mass with central necrosis and edema that can cross the corpus callosum ('butterfly glioma'). Oligodendroglioma (IDH-mutant, 1p/19q-codeleted) shows 'fried-egg' cells and calcification and carries a better prognosis. Metastatic disease seeds via hematogenous spread, typically lodging at gray-white junctions of watershed arterial territories. Mass effect, vasogenic edema, and disruption of the blood-brain barrier produce the clinical syndrome.

Clinical presentation

Symptoms

  • Progressive focal deficit referable to tumor location (hemiparesis, aphasia, visual field cut)
  • New-onset seizure in an adult — high suspicion for structural lesion
  • Headache: worse in morning, with Valsalva, awakening from sleep; ~50% at presentation
  • Cognitive or personality change, particularly with frontal tumors
  • Nausea, vomiting, and papilledema with elevated intracranial pressure

Signs / physical exam

  • Focal neurologic deficits on exam
  • Papilledema (late, indicates raised ICP)
  • Cushing reflex (hypertension, bradycardia, irregular respirations) — herniation imminent
  • Cranial nerve palsies (especially with skull-base, cerebellopontine angle, or brainstem tumors)

Classic findings

Adult with new seizure + progressive headache + focal deficit = brain tumor until imaging proves otherwise.

Differential diagnosis

  • Brain abscess — Fever, ring-enhancing lesion with restricted diffusion on DWI, recent dental work, endocarditis, or sinus/otologic source
  • Primary CNS lymphoma — Periventricular, deep gray, or corpus callosum involvement; homogeneous enhancement; restricted diffusion; HIV or immunosuppression; AVOID empiric steroids before biopsy
  • Demyelinating disease (MS, tumefactive) — Open-ring enhancement, less edema than tumor, oligoclonal bands in CSF, age <50, prior episodes
  • Ischemic stroke or subacute hemorrhage — Vascular territory, acute onset, evolution on serial imaging, no progressive growth
  • Neurocysticercosis — Endemic exposure, multiple cystic lesions with scolex, calcifications; serum EITB serology supports the diagnosis (peripheral eosinophilia usually absent)
  • Subdural empyema or hematoma — Crescentic extra-axial collection, trauma or sinusitis history

Diagnostic workup

Diagnostic criteria

Imaging suggests but never confirms — histology with WHO 2021 grading (CNS WHO grade 1-4, assigned within each tumor type) plus molecular markers (IDH, MGMT methylation, 1p/19q codeletion, ATRX, TERT) defines the tumor.

Labs

  • CBC, CMP, coagulation studies
  • If metastatic suspected: tumor markers and staging labs guided by likely primary
  • HIV serology if lymphoma considered

Imaging

  • MRI brain with and without gadolinium — modality of choice; characterizes edema, enhancement pattern, location
  • CT head if MRI unavailable or to evaluate acute mass effect, hemorrhage, or calcifications
  • CT chest/abdomen/pelvis and/or PET-CT to identify primary if metastasis suspected
  • Stereotactic biopsy or open resection for tissue diagnosis and molecular profiling

Diagnostic algorithm

flowchart TD
  A[New focal deficit,<br/>seizure, or<br/>progressive headache] --> B[MRI brain<br/>with contrast]
  B --> C{Single or<br/>multiple lesions?}
  C -->|Multiple, gray-white<br/>junction| D[Metastatic<br/>workup CT C/A/P]
  C -->|Single intra-axial<br/>infiltrative| E[Likely primary<br/>glioma]
  C -->|Extra-axial<br/>dural-based| F[Likely<br/>meningioma]
  D --> G[Find primary;<br/>SRS vs resection<br/>+ systemic Rx]
  E --> H[Resection +<br/>histology +<br/>molecular markers]
  F --> I[Observe vs<br/>resect vs SRS<br/>by size and grade]
  H --> J[Stupp protocol<br/>if GBM]
Diagnostic and management pathway for newly identified brain mass.

Treatment

First-line

  • Dexamethasone 4-10 mg IV/PO load, then 4 mg q6h for symptomatic vasogenic edema (HOLD if lymphoma suspected and biopsy planned)
  • Levetiracetam, lacosamide, or valproate for tumor-related seizures (avoid enzyme-inducing AEDs that interact with chemotherapy)
  • Neurosurgical consultation for maximal safe resection
  • VTE prophylaxis while hospitalized or perioperatively (brain tumor patients are hypercoagulable); routine outpatient prophylaxis is not recommended

Glioblastoma (WHO grade 4, IDH-wildtype)

  • Maximal safe resection
  • Stupp protocol: radiotherapy 60 Gy + concurrent temozolomide, then 6 cycles adjuvant temozolomide
  • Tumor-treating fields (Optune) may be added to adjuvant therapy
  • Bevacizumab for recurrence or symptomatic edema refractory to steroids

Meningioma

  • Observation for small asymptomatic WHO grade 1 tumors with serial MRI
  • Resection for symptomatic, growing, or atypical/anaplastic tumors
  • Stereotactic radiosurgery for surgically inaccessible or residual disease

Brain metastases

  • Solitary or oligometastatic (≤3-4): surgical resection or stereotactic radiosurgery
  • Multiple metastases: stereotactic radiosurgery preferred over whole-brain RT to spare cognition
  • Systemic therapy directed at primary tumor (CNS-penetrant agents: osimertinib for EGFR-mutant NSCLC, alectinib for ALK, BRAF/MEK inhibitors for melanoma)
  • Immunotherapy increasingly used (pembrolizumab, nivolumab, ipilimumab) for select tumors

Second-line / adjunct

  • Palliative care integration early in high-grade disease
  • Hospice for end-stage refractory tumors

Complications

  • Cerebral herniation (uncal, central, tonsillar) — neurosurgical emergency; uncal herniation compresses the ipsilateral CN III (fixed, dilated pupil) with contralateral hemiparesis, declining consciousness, and, as a late sign, the Cushing reflex; treat with head-of-bed elevation, hyperosmolar therapy (mannitol or hypertonic saline), dexamethasone for tumor edema, brief hyperventilation only as a bridge, and emergent neurosurgery
  • Status epilepticus
  • Hydrocephalus from CSF outflow obstruction
  • Radiation necrosis (months to years post-RT, may mimic recurrence on imaging)
  • Chemotherapy toxicity (cytopenias, hepatotoxicity, PCP pneumonia with prolonged steroids)
  • Cognitive decline from disease and treatment

PANCE pearls

  • Ring-enhancing lesion in an adult: MAGIC DR mnemonic — Metastasis, Abscess, Glioma, Infarct (subacute), CNS lymphoma (in immunocompromised), Demyelination, Radiation necrosis.
  • Multiple ring-enhancing lesions at gray-white junction in a smoker = metastatic disease until proven otherwise.
  • Steroids dramatically shrink lymphoma — withhold until tissue is obtained or diagnosis becomes obscured.
  • MGMT promoter methylation predicts temozolomide response in GBM.
  • Meningiomas calcify, often have a dural tail on MRI, and are typically extra-axial.
  • Pediatric brain tumors (the most common solid tumors of childhood) are often in the posterior fossa: pilocytic astrocytoma is the most common (benign cerebellar cyst with a mural nodule); medulloblastoma is the most common malignant one (midline vermis/fourth ventricle mass with ataxia, morning headache and vomiting, and obstructive hydrocephalus; resection plus craniospinal radiation and chemotherapy).
  • Craniopharyngioma (Rathke pouch remnant) is the classic calcified, partly cystic suprasellar tumor of childhood: headache, bitemporal hemianopia, central diabetes insipidus, and growth failure from GH deficiency; germinoma is the typically non-calcified suprasellar cause of central DI.

References

  • WHO 2021 — Louis DN et al. The 2021 WHO Classification of Tumors of the Central Nervous System. Neuro-Oncology 2021;23:1231-1251.
  • NCCN — NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers (current version).
  • Stupp Trial — Stupp R et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. NEJM 2005;352:987-996.
  • ASCO/SNO/ASTRO 2022 — Vogelbaum MA et al. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol 2022;40:492-516.

Practice Neurology questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.